How do you manage aromatase inhibitor- associated musculoskeletal syndrome (AIMSS) symptoms in post-menopausal breast cancer patients?

Available published data suggests that switching from one AI to another, does help to reduce AIMSS. This strategy is associated with improvement in AIMSS about 50% of the time (in published literature). From personal experience, letrozole tends to cause the most symptoms since from pharmacologic sta...

I have luck with the use of Vitamin D , chondroitin sulfate and Glucosamine in some patients.